Ditch Get-Rich-Quick Tips: Radhika Gupta Reveals the Real Path to a ₹100-Crore Portfolio
Source: Economictimes
Edelweiss Mutual Fund MD Radhika Gupta warns retail investors against chasing speculative social media tips for instant wealth. She emphasizes that long-term financial success comes from moderate return expectations, disciplined asset allocation, and increasing one's primary income.
Your dream home loan @ 8.4%*
Compare offers from 20+ banks in one click.
In an era of viral social media 'finfluencers' promising overnight riches, Radhika Gupta, Managing Director and CEO of Edelweiss Mutual Fund, has issued a reality check for Indian retail investors. She asserts that the journey to a massive ₹100-crore portfolio is built on the unglamorous foundations of patience, asset allocation, and the power of compounding, rather than speculative tips found on the internet.
Resetting Return Expectations
One of the biggest hurdles for modern investors is the distortion of what constitutes a 'good' return. Gupta points out that social media often portrays double-digit monthly gains as the norm, leading to frustration among disciplined savers. However, she advises investors to embrace a more realistic outlook.
- Accepting Normalcy: Investors should view annual returns of 10-12% as a success rather than a failure.
- Long-term View: Wealth creation is a marathon, not a sprint; chasing unsustainable returns often leads to capital erosion.
- Avoid Comparisons: Comparing your portfolio to curated, high-risk screenshots on social media can lead to poor emotional decision-making.
The Strategy: Allocation Over Selection
While many investors spend hundreds of hours trying to pick the single 'best' mutual fund or stock, Gupta suggests that this focus is misplaced. According to her, asset allocation—how you divide your money between equity, debt, and other asset classes—is far more critical to long-term success than individual fund selection.
By maintaining a balanced portfolio, investors can survive market volatility without panicking. This discipline allows compounding to work its magic over decades, which is the only reliable way to reach high-net-worth milestones.
Invest in Your 'Earning Machine'
A unique pillar of Gupta’s advice involves focusing on the source of the investment: yourself. She emphasizes that the most effective way to grow a portfolio is to increase the amount of capital you can deploy. This means focusing on your career or business to boost your primary income.
The formula for a ₹100-crore portfolio isn't just about the percentage return; it is about the consistency of the surplus generated from your profession. When a higher income meets disciplined asset allocation and a 10-12% return profile, the math of compounding becomes unstoppable.
The Discipline Verdict
Ultimately, Gupta warns that the desire for quick gains distorts investor behavior, leading them away from proven paths. Consistent discipline, rather than catching the next 'multibagger' trend, remains the only credible roadmap to significant financial freedom in the Indian market.
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. This content is for informational purposes only and does not constitute financial advice.
Some listings may be sponsored. Mutual fund data is from AMFI and for information only — funds are subject to market risks. Review terms & suitability before investing. Not investment advice.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Mutual Funds
HDFC Mutual Fund and ADIA Invest ₹777 Crore in Pharma Firm Corona Remedies
Major institutional investors, led by HDFC Mutual Fund and the Abu Dhabi Investment Authority (ADIA), have acquired stakes in Corona Remedies via a massive block deal. The shares were offloaded by existing investors Sepia Investments and Anchor Partners for approximately ₹777 crore.
MF Giants Buy Over 1 Crore Shares in 6 Stocks; Yes Bank & Central Bank Top List
Mutual fund houses significantly ramped up their holdings in May, adding over 1 crore shares each in six specific stocks. This surge in institutional backing coincides with impressive price rallies of up to 25% in these counters.
Don't Rely Solely on Indian Markets: Why You Need Global Stocks in Your Portfolio
Financial experts are urging Indian investors to break their 'home-country bias' and diversify into international markets. By investing in global equities, retail investors can protect their wealth against domestic volatility, inflation, and currency fluctuations.
Related Stories
HDFC ಮ್ಯೂಚುಯಲ್ ಫಂಡ್ ಮತ್ತು ADIA ಫಾರ್ಮಾ ಸಂಸ್ಥೆ ಕೊರೋನಾ ರೆಮಿಡೀಸ್ನಲ್ಲಿ ₹777 ಕೋಟಿ ಹೂಡಿಕೆ ಮಾಡಿದೆ
HDFC ಮ್ಯೂಚುಯಲ್ ಫಂಡ್ ಮತ್ತು ಅಬುಧಾಬಿ ಇನ್ವೆಸ್ಟ್ಮೆಂಟ್ ಅಥಾರಿಟಿ (ADIA) ನೇತೃತ್ವದ ಪ್ರಮುಖ ಸಾಂಸ್ಥಿಕ ಹೂಡಿಕೆದಾರರು ಬೃಹತ್ ಬ್ಲಾಕ್ ಡೀಲ್ ಮೂಲಕ ಕೊರೋನಾ ರೆಮಿಡೀಸ್ನಲ್ಲಿ ಪಾಲನ್ನು ಪಡೆದುಕೊಂಡಿದ್ದಾರೆ. ಅಸ್ತಿತ್ವದಲ್ಲಿರುವ ಹೂಡಿಕೆದಾರರಾದ ಸೆಪಿಯಾ ಇನ್ವೆಸ್ಟ್ಮೆಂಟ್ಸ್ ಮತ್ತು ಆಂಕರ್ ಪಾರ್ಟ್ನರ್ಸ್ ಸುಮಾರು ₹777 ಕೋಟಿ ಮೊತ್ತದ ಷೇರುಗಳನ್ನು ಮಾರಾಟ ಮಾಡಿದ್ದಾರೆ.
HDFC Mutual Fund और ADIA ने फार्मा कंपनी Corona Remedies में ₹777 करोड़ का निवेश किया
HDFC Mutual Fund और Abu Dhabi Investment Authority (ADIA) के नेतृत्व में प्रमुख संस्थागत निवेशकों ने एक विशाल ब्लॉक डील (block deal) के माध्यम से Corona Remedies में हिस्सेदारी हासिल की है। ये शेयर मौजूदा निवेशकों Sepia Investments और Anchor Partners द्वारा लगभग ₹777 करोड़ में बेचे गए।
एचडीएफसी म्युच्युअल फंड आणि ADIA कडून फार्मा कंपनी कोरोना रेमेडीजमध्ये ₹७७७ कोटींची गुंतवणूक
एचडीएफसी म्युच्युअल फंड आणि अबु धाबी इन्व्हेस्टमेंट अथॉरिटी (ADIA) यांच्या नेतृत्वाखालील प्रमुख संस्थात्मक गुंतवणूकदारांनी एका मोठ्या ब्लॉक डीलद्वारे कोरोना रेमेडीजमधील हिस्सा खरेदी केला आहे. विद्यमान गुंतवणूकदार सेपिया इन्व्हेस्टमेंट्स आणि अँकर पार्टनर्स यांनी अंदाजे ₹७७७ कोटींचे शेअर्स विकले आहेत.
HDFC Mutual Fund and ADIA Invest ₹777 Crore in Pharma Firm Corona Remedies
Major institutional investors, led by HDFC Mutual Fund and the Abu Dhabi Investment Authority (ADIA), have acquired stakes in Corona Remedies via a massive block deal. The shares were offloaded by existing investors Sepia Investments and Anchor Partners for approximately ₹777 crore.